ID

14007

Descripción

This is an open-label (all people know the identity of the intervention), multicenter study in genotype 1 chronic HCV infected liver transplant patients who will be treated for 12 weeks with telaprevir 750 mg every 8 hours given in combination with Peg-IFN-alfa-2a and ribavirin followed by 36 weeks of treatment with Peg-IFN-alfa-2a and ribavirin alone. The total treatment duration will be 48 weeks. Safety will be evaluated throughout the study and will include evaluations of adverse events, clinical laboratory tests, electrocardiogram, vital signs, and physical examination. NCT01571583

Palabras clave

Versiones (1)
  1. 22/3/16 22/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

22 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

Inglés

VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

1 formularios  
First Intakes Of Study Medication
Descripción

First Intakes Of Study Medication

actual date and time of first intake of telaprevir during this trial
Descripción

first intake of telaprevir

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C1876229
UMLS CUI [1,2]
C3174092
UMLS CUI [1,3]
C0205435
UMLS CUI [1,4]
C0011008
actual date of first intake of ribavirin during this trial
Descripción

date of first intake of ribavirin

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0035525
UMLS CUI [1,2]
C3174092
UMLS CUI [1,3]
C0205435
UMLS CUI [1,4]
C0011008
actual date and time of first administration of PEG-IFN during this trial
Descripción

date and time of first administration of PEG-IFN

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0907160
UMLS CUI [1,2]
C3174092
UMLS CUI [1,3]
C0205435
UMLS CUI [1,4]
C0011008
Volver a la parte superior de la página

Similar models

VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
First Intakes Of Study Medication
first intake of telaprevir
Item
actual date and time of first intake of telaprevir during this trial
datetime
C1876229 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
date of first intake of ribavirin
Item
actual date of first intake of ribavirin during this trial
datetime
C0035525 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
date and time of first administration of PEG-IFN
Item
actual date and time of first administration of PEG-IFN during this trial
datetime
C0907160 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial